Skip to main content

Also known as: Hereditary Transthyretin Amyloidosis Genetic Test, ATTR Amyloidosis Genetic Test

Results: 3โ€“4 Weeks Sample: Whole Blood (EDTA)

Test Price

2,800 AED

โœ… Home Collection Available

๐Ÿ“‹ Results in 3โ€“4 Weeks

TTR Gene Amyloidosis Genetic Test (NGS) โ€“ 2,800 AED

Executive Summary & Core Metrics

Comprehensive next-generation sequencing for hereditary transthyretin (ATTR) amyloidosis with 99.9% diagnostic sensitivity.

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing
  • Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation
  • Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731

Test Overview & Methodology

This advanced NGS panel empowers neurologists, cardiologists, and geneticists to confirm hereditary ATTR amyloidosis, guide therapeutic decisions, and screen at-risk relatives. The test provides full coverage of the TTR gene coding exons and splice junctions.

Parameter Our Test (NGS) Competitor IHC/Biopsy
Precision 99.9% sensitivity for all known TTR variants Variable; may miss rare mutations
Methodology NGS with full gene coverage Immunohistochemistry (limited specificity)
Turnaround Time 3โ€“4 Weeks Results often non-diagnostic

Physician Insight & Safety Protocols

โ€œAs a consultant medical geneticist, I witness the transformative power of early genetic diagnosis in ATTR patients. This NGS test provides definitive molecular clarity, enabling timely interventions that preserve quality of life. I strongly advise correlating molecular results with a comprehensive clinical evaluation and family pedigree analysis. Genetic counselling is essential before and after testing.โ€ โ€“ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Pre-Test Advisory

  • Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results should guide, not replace, clinical management.
  • Prior genetic counselling is mandatory for all patients and asymptomatic relatives to ensure informed consent and understanding of implications.
  • Results may identify variants of uncertain significance (VUS) that require further family segregation studies.

Exclusion Criteria & Emergency Red Flags

  • Patients with acute illness or unstable conditions (e.g., uncontrolled heart failure) are excluded from home phlebotomy; hospital-based collection is required.
  • If you experience severe neuropathy, dysautonomia, or cardiac arrhythmias prior to testing, seek immediate emergency care.
  • This test is not intended for asymptomatic minors without prior genetics consultation and written informed consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the detection rate of this TTR gene test for hereditary amyloidosis?

With next-generation sequencing, our test detects over 99% of pathogenic TTR variants, delivering a definitive molecular diagnosis in hereditary ATTR amyloidosis. This NGS panel covers all coding exons and splice sites, ensuring even rare mutations are not missed.

2. How do I prepare for the blood sample collection at home?

No fasting is required; our certified phlebotomist arrives with a cold-chain transport kit, collecting a single 3โ€“5 mL EDTA whole blood sample. A prior genetic counselling session is mandatory to document the pedigree chart, as per DHA norms. Please avoid strenuous exercise 2 hours before.

3. Can this test be used for predictive screening of family members?

This genetic test identifies asymptomatic carriers among relatives of a confirmed ATTR patient, enabling early surveillance and prophylactic management. UAE regulations require written informed consent and post-genetic counselling for all predictive screenings.

UAE Regulatory & Data Privacy Adherence

  • All patient data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
  • Clinical testing safety and patient consent protocols are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
  • DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) under facility license number 1143, operating in Dubai Healthcare City.

Clinical & Logistical Metadata

Test Name TTR Gene Amyloidosis Genetic Test (NGS) โ€“ Hereditary Transthyretin Amyloidosis
Price (AED) 2,800 AED
Turnaround Time 3โ€“4 Weeks
Sample Type / Matrix Whole Blood (EDTA) โ€“ 3โ€“5 mL
Methodology Used Next-Generation Sequencing (NGS) โ€“ Full gene coverage of TTR coding exons and splice sites
ICD-10-CM Code E85.2 (Hereditary amyloidosis)
LOINC Code 82939-0 (TTR gene mutation analysis in Blood)
DHA Facility License & Laboratory Address 1143 | DNA Labs UAE | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

ุฏุนู… ุซู†ุงุฆูŠ ุงู„ู„ุบุฉ ู…ุชุงุญ

ุงู„ุชุญู‚ู‚ ู…ู† ุงู„ุชุบุทูŠุฉ ุงู„ุชุฃู…ูŠู†ูŠุฉ

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

ุชูˆู‚ู ุนู† ุงู„ุชุฎู…ูŠู†. ุฃุฑุณู„ ุตูˆุฑุฉ ู…ู† ุจุทุงู‚ุฉ ุงู„ุชุฃู…ูŠู† ูˆูˆุตูุฉ ุงู„ุทุจูŠุจ ุฅู„ู‰ ูุฑูŠู‚ ุงู„ุชุญู‚ู‚ ุงู„ู…ุนุชู…ุฏ ู…ู† ู‡ูŠุฆุฉ ุงู„ุตุญุฉ ุจุฏุจูŠ ุนุจุฑ ุงู„ูˆุงุชุณุงุจ. ุงุญุตู„ ุนู„ู‰ ุชุญุฏูŠุซ ุงู„ุญุงู„ุฉ ููŠ ุฏู‚ุงุฆู‚.

โœ… DHA Certified โœ… ISO 15189 โœ… HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

Preparation Required

["No fasting required", "Avoid strenuous exercise 2 hours before collection", "Prior genetic counselling is mandatory"]

Medically Reviewed by Dr. Lina Osama Zaki Quteineh

All content reviewed by qualified professionals for accuracy.

๐Ÿ…

ISMS 27001:2022

๐Ÿ“‹

ISO Accredited

๐Ÿ”’

HIPAA

All reports reviewed by DHA-Certified physicians